These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 25764477)

  • 1. A recombinant canine distemper virus expressing a modified rabies virus glycoprotein induces immune responses in mice.
    Li Z; Wang J; Yuan D; Wang S; Sun J; Yi B; Hou Q; Mao Y; Liu W
    Virus Genes; 2015 Jun; 50(3):434-41. PubMed ID: 25764477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant canine distemper virus serves as bivalent live vaccine against rabies and canine distemper.
    Wang X; Feng N; Ge J; Shuai L; Peng L; Gao Y; Yang S; Xia X; Bu Z
    Vaccine; 2012 Jul; 30(34):5067-72. PubMed ID: 22698451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycoprotein from street rabies virus BD06 induces early and robust immune responses when expressed from a non-replicative adenovirus recombinant.
    Wang S; Sun C; Zhang S; Zhang X; Liu Y; Wang Y; Zhang F; Wu X; Hu R
    Arch Virol; 2015 Sep; 160(9):2315-23. PubMed ID: 26143474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivated Recombinant Rabies Viruses Displaying Canine Distemper Virus Glycoproteins Induce Protective Immunity against Both Pathogens.
    da Fontoura Budaszewski R; Hudacek A; Sawatsky B; Krämer B; Yin X; Schnell MJ; von Messling V
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological and immunogenic properties of rabies virus glycoprotein expressed by canine herpesvirus vector.
    Xuan X; Tuchiya K; Sato I; Nishikawa Y; Onoderaz Y; Takashima Y; Yamamoto A; Katsumata A; Iwata A; Ueda S; Mikami T; Otsuka H
    Vaccine; 1998; 16(9-10):969-76. PubMed ID: 9682345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and immunogenicity of a recombinant pseudotype baculovirus expressing the glycoprotein of rabies virus in mice.
    Huang H; Xiao S; Qin J; Jiang Y; Yang S; Li T; Gao Y; Li Z; Li T; Su X; Ruan Y; Xu F; Wang H; Chen H; Xia X
    Arch Virol; 2011 May; 156(5):753-8. PubMed ID: 21221673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice.
    Li J; Faber M; Papaneri A; Faber ML; McGettigan JP; Schnell MJ; Dietzschold B
    Virology; 2006 Dec 5-20; 356(1-2):147-54. PubMed ID: 16938327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel rabies vaccine based on a recombinant parainfluenza virus 5 expressing rabies virus glycoprotein.
    Chen Z; Zhou M; Gao X; Zhang G; Ren G; Gnanadurai CW; Fu ZF; He B
    J Virol; 2013 Mar; 87(6):2986-93. PubMed ID: 23269806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new rabies vaccine based on a recombinant ORF virus (parapoxvirus) expressing the rabies virus glycoprotein.
    Amann R; Rohde J; Wulle U; Conlee D; Raue R; Martinon O; Rziha HJ
    J Virol; 2013 Feb; 87(3):1618-30. PubMed ID: 23175365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of a recombinant rabies Flury LEP virus carrying an additional G gene creates an improved seed virus for inactivated vaccine production.
    Tao L; Ge J; Wang X; Wen Z; Zhai H; Hua T; Zhao B; Kong D; Yang C; Bu Z
    Virol J; 2011 Sep; 8():454. PubMed ID: 21943337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and safety of recombinant rabies viruses used for oral vaccination of stray dogs and wildlife.
    Faber M; Dietzschold B; Li J
    Zoonoses Public Health; 2009 Aug; 56(6-7):262-9. PubMed ID: 19486317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nucleoside-modified mRNA vaccine forming rabies virus-like particle elicits strong cellular and humoral immune responses against rabies virus infection in mice.
    Liu J; Sun J; Ding X; Liu W; Wang Y; Wang Z; Peng H; Zhang Y; Su W; Jiang C
    Emerg Microbes Infect; 2024 Dec; 13(1):2389115. PubMed ID: 39129566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the immunogenicity of two inactivated recombinant rabies viruses overexpressing the glycoprotein.
    Navid MT; Li Y; Zhou M; Cui M; Fu ZF; Tang L; Zhao L
    Arch Virol; 2016 Oct; 161(10):2863-70. PubMed ID: 27438075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant rabies virus expressing the H protein of canine distemper virus protects dogs from the lethal distemper challenge.
    Wang FX; Zhang SQ; Zhu HW; Yang Y; Sun N; Tan B; Li ZG; Cheng SP; Fu ZF; Wen YJ
    Vet Microbiol; 2014 Dec; 174(3-4):362-371. PubMed ID: 25465178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chimeric rabies virus-like particles containing membrane-anchored GM-CSF enhances the immune response against rabies virus.
    Kang H; Qi Y; Wang H; Zheng X; Gao Y; Li N; Yang S; Xia X
    Viruses; 2015 Mar; 7(3):1134-52. PubMed ID: 25768031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetically modified rabies virus ERA strain is safe and induces long-lasting protective immune response in dogs after oral vaccination.
    Shuai L; Feng N; Wang X; Ge J; Wen Z; Chen W; Qin L; Xia X; Bu Z
    Antiviral Res; 2015 Sep; 121():9-15. PubMed ID: 26093157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the protective efficacy between single and combination of recombinant adenoviruses expressing complete and truncated glycoprotein, and nucleoprotein of the pathogenic street rabies virus in mice.
    Kim HH; Yang DK; Nah JJ; Song JY; Cho IS
    Virol J; 2017 Jun; 14(1):122. PubMed ID: 28646885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel approach to a rabies vaccine based on a recombinant single-cycle flavivirus vector.
    Giel-Moloney M; Rumyantsev AA; David F; Figueiredo M; Feilmeier B; Mebatsion T; Parrington M; Kleanthous H; Pugachev KV
    Vaccine; 2017 Dec; 35(49 Pt B):6898-6904. PubMed ID: 28899628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two potential recombinant rabies vaccines expressing canine parvovirus virion protein 2 induce immunogenicity to canine parvovirus and rabies virus.
    Luo J; Shi H; Tan Y; Niu X; Long T; Zhao J; Tian Q; Wang Y; Chen H; Guo X
    Vaccine; 2016 Aug; 34(37):4392-8. PubMed ID: 27449079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and solubilization of insect cell-based rabies virus glycoprotein and assessment of its immunogenicity and protective efficacy in mice.
    Ramya R; Mohana Subramanian B; Sivakumar V; Senthilkumar RL; Sambasiva Rao KR; Srinivasan VA
    Clin Vaccine Immunol; 2011 Oct; 18(10):1673-9. PubMed ID: 21813661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.